BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2000
View Archived Issues
Age and gender found to have significant effects on cardiovascular disease treatment outcomes
Read More
Chugai becomes eighth Japanese company to receive license for PDL patent
Read More
SkyePharma and Merck sign agreement for Geomatrix
Read More
Adderall reduces symptoms of ADHD more effectively than Ritalin
Read More
Angiotech signs license agreement with Alcon for delivery of paclitaxel
Read More
Boston Life Sciences achieves milestone in experimental spinal cord injury
Read More
Elan acquires Segix Italia
Read More
Angiogenesis inhibitor shows promise in Kaposi's sarcoma
Read More
AEterna begins recruiting for NIH-sponsored clinical trial with new lung cancer drug
Read More
Alexion reports on complement activation in cardiovascular disease and kidney damage
Read More
Onconase may be associated with survival benefit versus doxorubicin in certain UMM patients
Read More
Trial demonstrates efficacy of drug therapy and cognitive-behavioral therapy in panic disorder
Read More
Morphine dependency in mice blocked by the kappa-opioid receptor agonist TRK-820
Read More
CDP-571 results in Crohn's disease presented at DDW
Read More
Herbal preparation shows promise in IBS
Read More
Xoma highlights Q1 development progress
Read More
BXT-51072 shows potent antioxidant activity in active ulcerative colitis
Read More
EGF-genistein prevents restenosis in vivo
Read More
Infliximab acts as steroid-sparing agent in Crohn's disease
Read More
Novo Nordisk outlicenses Neurin class of compounds to ReNeuron
Read More
Genentech's rhuMAb-VEGF shows promise on several fronts; phase III trials in planning
Read More
Phase I results of Genta's lead antisense drug combined with chemotherapy reported at ASCO
Read More
Takeda describes new injectable antifungal agents
Read More
BE-54476, a new antibacterial substance produced by a species of Streptomyces
Read More
Microbially produced NO inhibitor presented by Pola
Read More
Duphar patent describes combination of activities useful for Rx of schizophrenia
Read More
Potent histamine H3 receptor ligands developed by Schering-Plough
Read More
Abbott synthesizes series with adenosine kinase-inhibitory activity
Read More
New compounds for inflammation emerge from R&D at the former Searle
Read More
Inhibitors of COX-2 with an imidazole structure revealed by Uriach
Read More